Dedifferentiation, transdifferentiation, and reprogramming: Future directions in regenerative medicine

71Citations
Citations of this article
102Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The main goal of regenerative medicine is to replace damaged tissue. To do this it is necessary to understand in detail the whole regeneration process including differentiated cells that can be converted into progenitor cells (dedifferentiation), cells that can switch into another cell type (transdifferentiation), and somatic cells that can be induced to become pluripotent cells (reprogramming). By studying the regenerative processes in both nonmammal and mammal models, natural or artificial processes could underscore the molecular and cellular mechanisms behind these phenomena and be used to create future regenerative strategies for humans. Copyright © 2013 by Thieme Medical Publishers, Inc.

Cite

CITATION STYLE

APA

Eguizabal, C., Montserrat, N., Veiga, A., & Belmonte, J. I. (2013). Dedifferentiation, transdifferentiation, and reprogramming: Future directions in regenerative medicine. Seminars in Reproductive Medicine, 31(1), 82–94. https://doi.org/10.1055/s-0032-1331802

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free